A unique pain program is helping complex surgical patients wean off opioids safely and effectively, while offering alternative ways to cope with their pain and improve how they function.
Yale researchers have identified racial disparities in the treatment of patients who are prescribed opioids for chronic pain. Black patients who receive opioids long-term are more likely than whites to be tested for illicit drug use. Of those who test positive, blacks are more likely to have their opioid prescriptions discontinued, said the researchers.
Viral suppression rates have nearly tripled in the US over the past 2 decades, but disparities still exist for younger persons and blacks living with HIV. Researchers say that newer, better-tolerated treatment regimens, such as fixed-drug combinations that include integrase strand transfer inhibitors (ISTIs), have likely contributed to these dramatic gains. Findings from an observational cohort study are published in Annals of Internal Medicine.
Medicaid expansion under the Affordable Care Act (ACA) was associated with an overall increase in people filling prescriptions for buprenorphine with naloxone, which is a treatment for opioid use disorder, as well as an increase in people filling prescriptions for opioid pain relievers (OPRs) paid for by Medicaid in a data analysis from five states.
A University of Texas at Arlington professor led a federal advisory group that has published its recommendations on the prevention of acute and chronic pain to the Federal Research Pain Strategy, an interagency committee that oversees the government's long-term strategic plan to support pain research.
A new study investigates pre-existing perceptions about pain medications by individuals with chronic pain and how these perceptions relate to patients' experiences with these medications. The study found that, despite strongly held beliefs about opioid and non-opioid medications, patients were often surprised by their own results from these drugs.
A new study in the journal Rheumatology indicates that being exposed to secondhand smoke in childhood could increase the risk of someone developing arthritis as an adult.
Differing levels of sex hormones, especially estrogens, may explain why many more women than men suffer from migraines. A study published today provides evidence that these hormones affect cell mechanisms that control responses to migraine triggers, offering a possible pathway to more effective, personalized treatments.
Platelet-rich plasma (PRP) is believed to provide pain relief and help improve joint function in degenerative joint disease, but a new study has shown that it does not act by promoting stem cell proliferation or enhance the cartilage formation capabilities of mesenchymal stem cells (MSCs).
A new study has shown that use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia (TGN) may produce long-term pain relief.